Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Related Articles


APSC Consensus Recommendations for MitraClip in MR

Yeo Khung Keong, Jack Wei Chieh Tan, David WM Muller,


Citation: European Cardiology Review 2021;16:e25.

Limus-eluting Stents with Poly-L-lactic Acid Coating

Junbo Ge,

Citation: Asia-Pacific Cardiology 2007;1(1):42-3

New Drugs in Interventional Cardiology

Robaayah Zambahari,

Citation: Asia-Pacific Cardiology 2007;1(1):36-9

Non-cardiac Surgery Following Drug-eluting Stents

Dev Pahlajani,

Citation: Asia-Pacific Cardiology 2007;1(1):40-1